Part 5: Acute coronary syndromes. 2015 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations

Resuscitation

Volumn 95, Issue , 2015, Pages e121-e146

  Nikolaou, Nikolaos I ^a   Welsford, Michelle ^a   Beygui, Farzin ^a   Bossaert, Leo ^a   Ghaemmaghami, Chris ^a   Nonogi, Hiroshi ^a   O'Connor, Robert E ^a   Pichel, Daniel R ^a   Scott, Tony ^a   Walters, Darren L ^a   Woolfrey, Karen G H ^a   Ali, Abdulaziz S ^a   Ching, Chi Keong ^a   Longeway, Michael ^a   Patocka, Catherine ^a   Roule, Vincent ^a   Salzberg, Simon ^a   Seto, Anthony V ^a  

^a NONE

Author keywords

Fibrinolysis; Non ST segment elevation acute coronary syndromes; Percutaneous coronary intervention; STEMI

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ENOXAPARIN; HEPARIN; HIRULOG; OXYGEN; PRASUGREL; TICAGRELOR; TROPONIN I; TROPONIN T; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; ANGIOGRAPHY; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; DECISION MAKING; DRUG EFFICACY; ELECTROCARDIOGRAM; EMERGENCY CARE; FIBRINOLYSIS; HEART CATHETERIZATION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART MUSCLE REVASCULARIZATION; HEART REINFARCTION; HUMAN; MORTALITY; OUT OF HOSPITAL CARDIAC ARREST; OUTCOME ASSESSMENT; OXYGEN THERAPY; PATIENT SELECTION; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPERFUSION; RESUSCITATION; RETURN OF SPONTANEOUS CIRCULATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; SYMPTOM; THERAPY DELAY; TIME TO TREATMENT; TREATMENT OUTCOME; CONSENSUS; EMERGENCY HEALTH SERVICE; EMERGENCY TREATMENT; PRACTICE GUIDELINE; STANDARDS;

ACUTE CORONARY SYNDROME; CARDIOPULMONARY RESUSCITATION; CONSENSUS; EMERGENCY MEDICAL SERVICES; EMERGENCY TREATMENT; HUMANS; PRACTICE GUIDELINES AS TOPIC;

EID: 84944895573     PISSN: 03009572     EISSN: 18731570     Source Type: Journal    
DOI: 10.1016/j.resuscitation.2015.07.043     Document Type: Article

References (127)

1. Institute of Medicine. Standards for systematic reviews. 〈http://www.iom.edu/Reports/2011/Finding-What-Works-in-Health-Care-Standards-for-Systematic-Reviews/Standards.aspx 2011. [accessed 06.05.15].
2. Schünemann H, Brozek J, Guyatt G, Oxman A. GRADE handbook. 〈http://www.guidelinedevelopment.org/handbook/ 2013. [accessed 06.05.15].
3. O'Connor D, Green S, Higgins JPT, editors. Chapter 5: Defining the review questions and developing criteria for including studies. In: The Cochrane collaboration. Higgins JPT, Green, S, editors. Cochrane handbook for systematic reviews of interventions. Version 5.1.0. 〈http://handbook.cochrane.org/ 2011. [accessed 06.05.15].
4. Higgins J, Altman D, Sterne J, editors. Chapter 8.5 The Cochrane Collaboration's tool for assessing risk of bias. In: The Cochrane collaboration. Higgins JPT, Green, S, editors. Cochrane Handbook for systematic reviews of interventions. Version 5.1.0. 〈http://handbook.cochrane.org/ 2011. [accessed 06.05.15].
5. Whiting P.F., Rutjes A.W., Westwood M.E., et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 2011, 155:529-536.
6. Schünemann H, Brozek J, Guyatt G, Oxman A. 5.2.1 Study limitations (risk of bias). In: GRADE handbook. 〈http://www.guidelinedevelopment.org/handbook/#h.m9385o5z3li7 2013. [accessed 06.05.15].
7. Evidence Prime Inc. GRADEpro guideline development tool. 〈http://www.guidelinedevelopment.org/〉. [accessed 06.05.15].
8. Schünemann H, Brozek J, Guyatt G, Oxman A. 5. Quality of evidence. In: GRADE handbook. 〈http://www.guidelinedevelopment.org/handbook/#h.9rdbelsnu4iy 2013. [accessed 06.05.15].
9. Schünemann H, Brozek J, Guyatt G, Oxman A. 5.1 Factors determining the quality of evidence. In: GRADE handbook. 〈http://www.guidelinedevelopment.org/handbook/#h.9rdbelsnu4iy 2013. [accessed 06.05.15].
10. Mendis S., Thygesen K., Kuulasmaa K., et al. Writing group on behalf of the participating experts of the WHO consultation for revision of WHO definition of myocardial infarction. World Health Organization definition of myocardial infarction: 2008-09 revision. Int J Epidemiol 2011, 40:139-146.
11. Canto J.G., Rogers W.J., Bowlby L.J., French W.J., Pearce D.J., Weaver W.D. The prehospital electrocardiogram in acute myocardial infarction: is its full potential being realized? National Registry of Myocardial Infarction 2 Investigators. J Am Coll Cardiol 1997, 29:498-505.
12. Terkelsen C.J., Lassen J.F., Nørgaard B.L., et al. Reduction of treatment delay in patients with ST-elevation myocardial infarction: impact of pre-hospital diagnosis and direct referral to primary percutanous coronary intervention. Eur Heart J 2005, 26:770-777.
13. Carstensen S., Nelson G.C., Hansen P.S., et al. Field triage to primary angioplasty combined with emergency department bypass reduces treatment delays and is associated with improved outcome. Eur Heart J 2007, 28:2313-2319.
14. Brown J.P., Mahmud E., Dunford J.V., Ben-Yehuda O. Effect of prehospital 12-lead electrocardiogram on activation of the cardiac catheterization laboratory and door-to-balloon time in ST-segment elevation acute myocardial infarction. Am J Cardiol 2008, 101:158-161.
15. Martinoni A., De Servi S., Boschetti E., et al. Importance and limits of pre-hospital electrocardiogram in patients with ST elevation myocardial infarction undergoing percutaneous coronary angioplasty. Eur J Cardiovasc Prev Rehabil 2011, 18:526-532.
16. Sørensen J.T., Terkelsen C.J., Nørgaard B.L., et al. Urban and rural implementation of pre-hospital diagnosis and direct referral for primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction. Eur Heart J 2011, 32:430-436.
17. Chan A.W., Kornder J., Elliott H., et al. Improved survival associated with pre-hospital triage strategy in a large regional ST-segment elevation myocardial infarction program. JACC Cardiovasc Interv 2012, 5:1239-1246.
18. Ong M.E., Wong A.S., Seet C.M., et al. Nationwide improvement of door-to-balloon times in patients with acute ST-segment elevation myocardial infarction requiring primary percutaneous coronary intervention with out-of-hospital 12-lead ECG recording and transmission. Ann Emerg Med 2013, 61:339-347.
19. Quinn T., Johnsen S., Gale C.P., et al. Effects of prehospital 12-lead ECG on processes of care and mortality in acute coronary syndrome: a linked cohort study from the Myocardial Ischaemia National Audit Project. Heart 2014, 100:944-950.
20. van de Loo A., Saurbier B., Kalbhenn J., Koberne F., Zehender M. Primary percutaneous coronary intervention in acute myocardial infarction: direct transportation to catheterization laboratory by emergency teams reduces door-to-balloon time. Clin Cardiol 2006, 29:112-116.
21. Caudle J.M., Piggott Z., Dostaler S., Graham K., Brison R.J. Impact of a rapid access protocol on decreasing door-to-balloon time in acute ST elevation myocardial infarction. CJEM 2009, 11:29-35.
22. Nestler D.M., White R.D., Rihal C.S., et al. Impact of prehospital electrocardiogram protocol and immediate catheterization team activation for patients with ST-elevation-myocardial infarction. Circ Cardiovasc Qual Outcomes 2011, 4:640-646.
23. Wall T., Albright J., Livingston B., et al. Prehospital ECG transmission speeds reperfusion for patients with acute myocardial infarction. N C Med J 2000, 61:104-108.
24. Swor R., Hegerberg S., McHugh-McNally A., Goldstein M., McEachin C.C. Prehospital 12-lead ECG: efficacy or effectiveness?. Prehosp Emerg Care 2006, 10:374-377.
25. Dhruva V.N., Abdelhadi S.I., Anis A., et al. ST-segment analysis using wireless technology in acute myocardial infarction (STAT-MI) trial. J Am Coll Cardiol 2007, 50:509-513.
26. Diercks D.B., Kontos M.C., Chen A.Y., et al. Utilization and impact of pre-hospital electrocardiograms for patients with acute ST-segment elevation myocardial infarction: data from the NCDR (National Cardiovascular Data Registry) ACTION (Acute Coronary Treatment and Intervention Outcomes Network) registry. J Am Coll Cardiol 2009, 53:161-166.
27. Karagounis L., Ipsen S.K., Jessop M.R., et al. Impact of field-transmitted electrocardiography on time to in-hospital thrombolytic therapy in acute myocardial infarction. Am J Cardiol 1990, 66:786-791.
28. Bhalla M.C., Mencl F., Gist M.A., Wilber S., Zalewski J. Prehospital electrocardiographic computer identification of ST-segment elevation myocardial infarction. Prehosp Emerg Care 2013, 17:211-216.
29. Clark E.N., Sejersten M., Clemmensen P., Macfarlane P.W. Automated electrocardiogram interpretation programs versus cardiologists' triage decision making based on teletransmitted data in patients with suspected acute coronary syndrome. Am J Cardiol 2010, 106:1696-1702.
30. de Champlain F., Boothroyd L.J., Vadeboncoeur A., et al. Computerized interpretation of the prehospital electrocardiogram: predictive value for ST segment elevation myocardial infarction and impact on on-scene time. CJEM 2014, 16:94-105.
31. Squire B.T., Tamayo-Sarver J.H., Rashi P., Koenig W., Niemann J.T. Effect of prehospital cardiac catheterization lab activation on door-to-balloon time, mortality, and false-positive activation. Prehosp Emerg Care 2014, 18:1-8.
32. Youngquist S.T., Shah A.P., Niemann J.T., Kaji A.H., French W.J. A comparison of door-to-balloon times and false-positive activations between emergency department and out-of-hospital activation of the coronary catheterization team. Acad Emerg Med 2008, 15:784-787.
33. van't Hof A.W., Rasoul S., van de Wetering H., et al. Feasibility and benefit of prehospital diagnosis, triage, and therapy by paramedics only in patients who are candidates for primary angioplasty for acute myocardial infarction. Am Heart J 2006, 151:1255.e5.
34. Feldman J.A., Brinsfield K., Bernard S., White D., Maciejko T. Real-time paramedic compared with blinded physician identification of ST-segment elevation myocardial infarction: results of an observational study. Am J Emerg Med 2005, 23:443-448.
35. Ducas R.A., Wassef A.W., Jassal D.S., et al. To transmit or not to transmit: how good are emergency medical personnel in detecting STEMI in patients with chest pain?. Can J Cardiol 2012, 28:432-437.
36. Trivedi K., Schuur J.D., Cone D.C. Can paramedics read ST-segment elevation myocardial infarction on prehospital 12-lead electrocardiograms?. Prehosp Emerg Care 2009, 13:207-214.
37. Davis D.P., Graydon C., Stein R., et al. The positive predictive value of paramedic versus emergency physician interpretation of the prehospital 12-lead electrocardiogram. Prehosp Emerg Care 2007, 11:399-402.
38. Lee C.H., Van Gelder C.M., Cone D.C. Early cardiac catheterization laboratory activation by paramedics for patients with ST-segment elevation myocardial infarction on prehospital 12-lead electrocardiograms. Prehosp Emerg Care 2010, 14:153-158.
39. Young D.R., Murinson M., Wilson C., et al. Paramedics as decision makers on the activation of the catheterization laboratory in the presence of acute ST-elevation myocardial infarction. J Electrocardiol 2011, 44:18-22.
40. Dorsch M.F., Greenwood J.P., Priestley C., et al. Direct ambulance admission to the cardiac catheterization laboratory significantly reduces door-to-balloon times in primary percutaneous coronary intervention. Am Heart J 2008, 155:1054-1058.
41. Strauss D.G., Sprague P.Q., Underhill K., et al. Paramedic transtelephonic communication to cardiologist of clinical and electrocardiographic assessment for rapid reperfusion of ST-elevation myocardial infarction. J Electrocardiol 2007, 40:265-270.
42. Le May M.R., Davies R.F., Dionne R., et al. Comparison of early mortality of paramedic-diagnosed ST-segment elevation myocardial infarction with immediate transport to a designated primary percutaneous coronary intervention center to that of similar patients transported to the nearest hospital. Am J Cardiol 2006, 98:1329-1333.
43. Horvath S.A., Xu K., Nwanyanwu F., et al. Impact of the prehospital activation strategy in patients with ST-elevation myocardial infarction undergoing primary percutaneous revascularization: a single center community hospital experience. Crit Pathways Cardiol 2012, 11:186-192.
44. Qiu J.P., Zhang Q., Lu J.D., et al. Direct ambulance transport to catheterization laboratory reduces door-to-balloon time in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: the DIRECT-STEMI study. Chin Med J (Engl) 2011, 124:805-810.
45. Thygesen K., Alpert J.S., Jaffe A.S., et al. Joint ESC/ACCF/AHA/WHF task force for the universal definition of myocardial infarction. Third universal definition of myocardial infarction. Circulation 2012, 126:2020-2035.
46. O'Connor R.E., Bossaert L., Arntz H.R., et al. Acute coronary syndrome chapter collaborators. Part 9: Acute coronary syndromes: 2010 international consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations. Circulation 2010, 122:S422-S465. [Suppl 2].
47. Bossaert L., O'Connor R.E., Arntz H.R., et al. Part 9: acute coronary syndromes: 2010 international consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations. Resuscitation 2010, 81:Se175-Se212. [Suppl 1].
48. Aldous S.J., Richards A.M., Cullen L., Than M.P. Early dynamic change in high-sensitivity cardiac troponin T in the investigation of acute myocardial infarction. Clin Chem 2011, 57:1154-1160.
49. Parsonage W.A., Greenslade J.H., Hammett C.J., et al. Validation of an accelerated high-sensitivity troponin T assay protocol in an Australian cohort with chest pain. Med J Aust 2014, 200:161-165.
50. Cullen L., Greenslade J.H., Than M., et al. The new Vancouver Chest Pain Rule using troponin as the only biomarker: an external validation study. Am J Emerg Med. 2014, 32:129-134.
51. Cullen L., Mueller C., Parsonage W.A., et al. Validation of high-sensitivity troponin I in a 2-hour diagnostic strategy to assess 30-day outcomes in emergency department patients with possible acute coronary syndrome. J Am Coll Cardiol 2013, 62:1242-1249.
52. Xavier Scheuermeyer F., Wong H., Yu E., et al. Development and validation of a prediction rule for early discharge of low-risk emergency department patients with potential ischemic chest pain. CJEM 2014, 16:106-119.
53. Kelly A.M., Klim S. Prospective external validation of an accelerated (2-h) acute coronary syndrome rule-out process using a contemporary troponin assay. Int J Emerg Med 2014, 7:42.
54. Mahler S.A., Miller C.D., Hollander J.E., et al. Identifying patients for early discharge: performance of decision rules among patients with acute chest pain. Int J Cardiol 2013, 168:795-802.
55. Hess E.P., Brison R.J., Perry J.J., et al. Development of a clinical prediction rule for 30-day cardiac events in emergency department patients with chest pain and possible acute coronary syndrome. Ann Emerg Med 2012, 59. 115.e1-125.e1.
56. Fox K.A., Steg P.G., Eagle K.A., et al. Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006. JAMA 2007, 297:1892-1900.
57. O'Gara P.T., Kushner F.G., Ascheim D.D., et al. American college of cardiology foundation/american heart association task force on practice guidelines. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American college of cardiology foundation/American heart association task force on practice guidelines. Circulation 2013, 127:e362-e425.
58. Steg P.G., James S.K., et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012, 33:2569-2619. Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology.
59. Zeymer U., Arntz H.R., Mark B., et al. Efficacy and safety of a high loading dose of clopidogrel administered prehospitally to improve primary percutaneous coronary intervention in acute myocardial infarction: the randomized CIPAMI trial. Clin Res Cardiol 2012, 101:305-312.
60. Ducci K., Grotti S., Falsini G., et al. Comparison of pre-hospital 600mg or 900mg vs. peri-interventional 300mg clopidogrel in patients with ST-elevation myocardial infarction undergoing primary coronary angioplasty. The Load&Go randomized trial. Int J Cardiol 2013, 168:4814-4816.
61. Montalescot G., van 't Hof A.W., Lapostolle F., et al. Prehospital ticagrelor in ST-segment elevation myocardial infarction. N Engl J Med 2014, 371:1016-1027.
62. Zijlstra F., Ernst N., de Boer M.J., et al. Influence of prehospital administration of aspirin and heparin on initial patency of the infarct-related artery in patients with acute ST elevation myocardial infarction. J Am Coll Cardiol 2002, 39:1733-1737.
63. Steg P.G., van 't Hof A., Hamm C.W., et al. Bivalirudin started during emergency transport for primary PCI. N Engl J Med 2013, 369:2207-2217.
64. Sejersten M., Nielsen S.L., Engstrøm T., Jørgensen E., Clemmensen P. Feasibility and safety of prehospital administration of bivalirudin in patients with ST-elevation myocardial infarction. Am J Cardiol 2009, 103:1635-1640.
65. Hirschl M.M., Mayr H., Erhart F., et al. Prehospital treatment of patients with acute myocardial infarction with bivalirudin. Am J Emerg Med 2012, 30:12-17.
66. Montalescot G., Zeymer U., Silvain J., et al. Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trial. Lancet 2011, 378:693-703.
67. Bangalore S., Toklu B., Kotwal A., et al. Anticoagulant therapy during primary percutaneous coronary intervention for acute myocardial infarction: a meta-analysis of randomized trials in the era of stents and P2Y12 inhibitors. BMJ 2014, 349:g6419.
68. Cavender M.A., Sabatine M.S. Bivalirudin versus heparin in patients planned for percutaneous coronary intervention: a meta-analysis of randomised controlled trials. Lancet 2014, 384:599-606.
69. Rawles J.M., Kenmure A.C. Controlled trial of oxygen in uncomplicated myocardial infarction. Br Med J 1976, 1:1121-1123.
70. Ukholkina G.B., Kostianov IIu, Kuchkina N.V., Grendo E.P., Gofman IaB Effect of oxygenotherapy used in combination with reperfusion in patients with acute myocardial infarction. Kardiologiia 2005, 45:59.
71. Ranchord A.M., Argyle R., Beynon R., et al. High-concentration versus titrated oxygen therapy in ST-elevation myocardial infarction: a pilot randomized controlled trial. Am Heart J 2012, 163:168-175.
72. Stub D., Smith K., Bernard S., et al. Air versus oxygen in ST-segment-elevation myocardial infarction. Circulation 2015, 131:2143-2150.
73. Wilson A.T., Channer K.S. Hypoxaemia and supplemental oxygen therapy in the first 24hours after myocardial infarction: the role of pulse oximetry. J R Coll Physicians Lond 1997, 31:657-661.
74. Castaigne A.D., Hervé C., Duval-Moulin A.M., et al. Prehospital use of APSAC: results of a placebo-controlled study. Am J Cardiol 1989, 64:30A-33A. [discussion 41A].
75. Schofer J., Büttner J., Geng G., et al. Prehospital thrombolysis in acute myocardial infarction. Am J Cardiol 1990, 66:1429-1433.
76. Weaver W.D., Cerqueira M., Hallstrom A.P., et al. Prehospital-initiated vs hospital-initiated thrombolytic therapy. The myocardial infarction triage and intervention trial. JAMA 1993, 270:1211-1216.
77. Zeymer U., Arntz H.R., Dirks B., et al. Reperfusion rate and inhospital mortality of patients with ST segment elevation myocardial infarction diagnosed already in the prehospital phase: results of the German Prehospital Myocardial Infarction Registry (PREMIR). Resuscitation 2009, 80:402-406.
78. Bonnefoy E., Lapostolle F., Leizorovicz A., et al. Comparison of angioplasty and prehospital thromboysis in acute myocardial infarction study group. Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study. Lancet 2002, 360:825-829.
79. Thiele H., Eitel I., Meinberg C., et al. Randomized comparison of pre-hospital-initiated facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention in acute myocardial infarction very early after symptom onset: the LIPSIA-STEMI trial (Leipzig immediate prehospital facilitated angioplasty in ST-segment myocardial infarction). JACC Cardiovasc Interv 2011, 4:605-614.
80. Armstrong P.W., Gershlick A.H., Goldstein P., et al. Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction. N Engl J Med 2013, 368:1379-1387.
81. Armstrong P.W. A comparison of pharmacologic therapy with/without timely coronary intervention vs. primary percutaneous intervention early after ST-elevation myocardial infarction: the WEST (Which Early ST-elevation myocardial infarction Therapy) study. Eur Heart J 2006, 27:1530-1538. WEST Steering Committee.
82. Sinnaeve P.R., Armstrong P.W., Gershlick A.H., et al. ST-segment-elevation myocardial infarction patients randomized to a pharmaco-invasive strategy or primary percutaneous coronary intervention: strategic reperfusion early after myocardial infarction (STREAM) 1-year mortality follow-up. Circulation 2014, 130:1139-1145.
83. Ellis S.G., Tendera M., de Belder M.A., et al. Facilitated PCI in patients with ST-elevation myocardial infarction. N Engl J Med 2008, 358:2205-2217.
84. Itoh T., Fukami K., Suzuki T., et al. Comparison of long-term prognostic evaluation between pre-intervention thrombolysis and primary coronary intervention: a prospective randomized trial: five-year results of the IMPORTANT study. Circ J 2010, 74:1625-1634.
85. Kurihara H., Matsumoto S., Tamura R., et al. Clinical outcome of percutaneous coronary intervention with antecedent mutant t-PA administration for acute myocardial infarction. Am Heart J 2004, 147:E14.
86. Thiele H., Scholz M., Engelmann L., et al. ST-segment recovery and prognosis in patients with ST-elevation myocardial infarction reperfused by prehospital combination fibrinolysis, prehospital initiated facilitated percutaneous coronary intervention, or primary percutaneous coronary intervention. Am J Cardiol 2006, 98:1132-1139.
87. Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial. Lancet 2006, 367:569-578. Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT-4 PCI) investigators.
88. Westerhout C.M., Bonnefoy E., Welsh R.C., Steg P.G., Boutitie F., Armstrong P.W. The influence of time from symptom onset and reperfusion strategy on 1-year survival in ST-elevation myocardial infarction: a pooled analysis of an early fibrinolytic strategy versus primary percutaneous coronary intervention from CAPTIM and WEST. Am Heart J 2011, 161:283-290.
89. Bonnefoy E., Steg P.G., Boutitie F., et al. Comparison of primary angioplasty and pre-hospital fibrinolysis in acute myocardial infarction (CAPTIM) trial: a 5-year follow-up. Eur Heart J 2009, 30:1598-1606.
90. Steg P.G., Bonnefoy E., Chabaud S., et al. Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM randomized clinical trial. Circulation 2003, 108:2851-2856.
91. Widimský P., Budesínský T., Vorác D., et al. Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial-PRAGUE-2. Eur Heart J 2003, 24:94-104.
92. Tarantini G., Razzolini R., Napodano M., Bilato C., Ramondo A., Iliceto S. Acceptable reperfusion delay to prefer primary angioplasty over fibrin-specific thrombolytic therapy is affected (mainly) by the patient's mortality risk: 1h does not fit all. Eur Heart J 2010, 31:676-683.
93. Widimsky P. Primary angioplasty vs. thrombolysis: the end of the controversy?. Eur Heart J 2010, 31:634-636.
94. Pinto D.S., Kirtane A.J., Nallamothu B.K., et al. Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy. Circulation 2006, 114:2019-2025.
95. Pinto D.S., Frederick P.D., Chakrabarti A.K., et al. Benefit of transferring ST-segment-elevation myocardial infarction patients for percutaneous coronary intervention compared with administration of onsite fibrinolytic declines as delays increase. Circulation 2011, 124:2512-2521.
96. Andersen H.R., Nielsen T.T., Rasmussen K., et al. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 2003, 349:733-742.
97. Dieker H.J., van Horssen E.V., Hersbach F.M., et al. Transport for abciximab facilitated primary angioplasty versus on-site thrombolysis with a liberal rescue policy: the randomised Holland Infarction Study (HIS). J Thromb Thrombolysis 2006, 22:39-45.
98. Dobrzycki S., Kralisz P., Nowak K., et al. Transfer with GP IIb/IIIa inhibitor tirofiban for primary percutaneous coronary intervention vs. on-site thrombolysis in patients with ST-elevation myocardial infarction (STEMI): a randomized open-label study for patients admitted to community hospitals. Eur Heart J 2007, 28:2438-2448.
99. Grines C.L., Westerhausen D.R., Grines L.L., et al. A randomized trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarction: the air primary angioplasty in myocardial infarction study. J Am Coll Cardiol 2002, 39:1713-1719.
100. Svensson L., Aasa M., Dellborg M., et al. Comparison of very early treatment with either fibrinolysis or percutaneous coronary intervention facilitated with abciximab with respect to ST recovery and infarct-related artery epicardial flow in patients with acute ST-segment elevation myocardial infarction: the Swedish Early Decision (SWEDES) reperfusion trial. Am Heart J 2006, 151:798.e1-798.e7.
101. Vermeer F., Oude Ophuis A.J., vd Berg E.J., et al. Prospective randomised comparison between thrombolysis, rescue PTCA, and primary PTCA in patients with extensive myocardial infarction admitted to a hospital without PTCA facilities: a safety and feasibility study. Heart 1999, 82:426-431.
102. Widimský P., Groch L., Zelízko M., Aschermann M., Bednár F., Suryapranata H. Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE study. Eur Heart J 2000, 21:823-831.
103. Fernández-Avilés F., Alonso J.J., Peña G., et al. Primary angioplasty vs. early routine post-fibrinolysis angioplasty for acute myocardial infarction with ST-segment elevation: the GRACIA-2 non-inferiority, randomized, controlled trial. Eur Heart J 2007, 28:949-960.
104. Danchin N., Coste P., Ferrières J., et al. Comparison of thrombolysis followed by broad use of percutaneous coronary intervention with primary percutaneous coronary intervention for ST-segment-elevation acute myocardial infarction: data from the french registry on acute ST-elevation myocardial infarction (FAST-MI). Circulation 2008, 118:268-276.
105. Scheller B., Hennen B., Hammer B., et al. Beneficial effects of immediate stenting after thrombolysis in acute myocardial infarction. J Am Coll Cardiol 2003, 42:634-641.
106. Fernandez-Avilés F., Alonso J.J., Castro-Beiras A., et al. Routine invasive strategy within 24hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomised controlled trial. Lancet 2004, 364:1045-1053.
107. Le May M.R., Wells G.A., Labinaz M., et al. Combined angioplasty and pharmacological intervention versus thrombolysis alone in acute myocardial infarction (CAPITAL AMI study). J Am Coll Cardiol 2005, 46:417-424.
108. Cantor W.J., Fitchett D., Borgundvaag B., et al. Routine early angioplasty after fibrinolysis for acute myocardial infarction. N Engl J Med 2009, 360:2705-2718.
109. Bøhmer E., Hoffmann P., Abdelnoor M., Arnesen H., Halvorsen S. Efficacy and safety of immediate angioplasty versus ischemia-guided management after thrombolysis in acute myocardial infarction in areas with very long transfer distances results of the NORDISTEMI (NORwegian study on DIstrict treatment of ST-elevation myocardial infarction). J Am Coll Cardiol 2010, 55:102-110.
110. Bednár F., Widimský P., Krupicka J., et al. Interhospital transport for primary angioplasty improves the long-term outcome of acute myocardial infarction compared with immediate thrombolysis in the nearest hospital (one-year follow-up of the PRAGUE-1 study). Can J Cardiol 2003, 19:1133-1137.
111. Bagai A., Cantor W.J., Tan M., et al. Clinical outcomes and cost implications of routine early PCI after fibrinolysis: one-year follow-up of the trial of routine angioplasty and stenting after fibrinolysis to enhance reperfusion in acute myocardial infarction (TRANSFER-AMI) study. Am Heart J 2013, 165. 630.e2-637.e2.
112. Dumas F., Cariou A., Manzo-Silberman S., et al. Immediate percutaneous coronary intervention is associated with better survival after out-of-hospital cardiac arrest: insights from the PROCAT (Parisian Region Out of hospital Cardiac ArresT) registry. Circ Cardiovasc Interv 2010, 3:200-207.
113. Hollenbeck R.D., McPherson J.A., Mooney M.R., et al. Early cardiac catheterization is associated with improved survival in comatose survivors of cardiac arrest without STEMI. Resuscitation 2014, 85:88-95.
114. Mooney M.R., Unger B.T., Boland L.L., et al. Therapeutic hypothermia after out-of-hospital cardiac arrest: evaluation of a regional system to increase access to cooling. Circulation 2011, 124:206-214.
115. Gräsner J.T., Meybohm P., Lefering R., et al. ROSC after cardiac arrest-the RACA score to predict outcome after out-of-hospital cardiac arrest. Eur Heart J 2011, 32:1649-1656.
116. Cronier P., Vignon P., Bouferrache K., et al. Impact of routine percutaneous coronary intervention after out-of-hospital cardiac arrest due to ventricular fibrillation. Crit Care 2011, 15:R122.
117. Bulut S., Aengevaeren W.R., Luijten H.J., Verheugt F.W. Successful out-of-hospital cardiopulmonary resuscitation: what is the optimal in-hospital treatment strategy?. Resuscitation 2000, 47:155-161.
118. Bro-Jeppesen J., Kjaergaard J., Wanscher M., et al. Emergency coronary angiography in comatose cardiac arrest patients: do real-life experiences support the guidelines?. Eur Heart J Acute Cardiovasc Care 2012, 1:291-301.
119. Aurore A., Jabre P., Liot P., Margenet A., Lecarpentier E., Combes X. Predictive factors for positive coronary angiography in out-of-hospital cardiac arrest patients. Eur J Emerg Med 2011, 18:73-76.
120. Nanjayya V.B., Nayyar V. Immediate coronary angiogram in comatose survivors of out-of-hospital cardiac arrest-an Australian study. Resuscitation 2012, 83:699-704.
121. Reynolds J.C., Callaway C.W., El Khoudary S.R., Moore C.G., Alvarez R.J., Rittenberger J.C. Coronary angiography predicts improved outcome following cardiac arrest: propensity-adjusted analysis. J Intensive Care Med 2009, 24:179-186.
122. Strote J.A., Maynard C., Olsufka M., et al. Comparison of role of early (less than sixhours) to later (more than sixhours) or no cardiac catheterization after resuscitation from out-of-hospital cardiac arrest. Am J Cardiol 2012, 109:451-454.
123. Tømte O., Andersen GØ, Jacobsen D., Drægni T., Auestad B., Sunde K. Strong and weak aspects of an established post-resuscitation treatment protocol-A five-year observational study. Resuscitation 2011, 82:1186-1193.
124. Waldo S.W., Armstrong E.J., Kulkarni A., et al. Comparison of clinical characteristics and outcomes of cardiac arrest survivors having versus not having coronary angiography. Am J Cardiol 2013, 111:1253-1258.
125. Nielsen N., Hovdenes J., Nilsson F., et al. Outcome, timing and adverse events in therapeutic hypothermia after out-of-hospital cardiac arrest. Acta Anaesthesiol Scand 2009, 53:926-934.
126. Werling M., Thorén A.B., Axelsson C., Herlitz J. Treatment and outcome in post-resuscitation care after out-of-hospital cardiac arrest when a modern therapeutic approach was introduced. Resuscitation 2007, 73:40-45.
127. Zanuttini D., Armellini I., Nucifora G., et al. Impact of emergency coronary angiography on in-hospital outcome of unconscious survivors after out-of-hospital cardiac arrest. Am J Cardiol 2012, 110:1723-1728.